MHY 553
MHY 553 is a PPARα agonist that is effective when taken orally. MHY 553 helps alleviate liver fat accumulation by increasing fatty acid oxidation and reducing inflammation during the aging process. MHY 553 inhibits the accumulation of triglycerides induced by liver X receptor agonists in HepG2 cells. MHY 553 significantly suppresses the expression of inflammatory mRNA in aging rats.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 6265-56-1
- Fòrmula: C13H9NO2S
- Peso molecular:243.28
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Protocolo
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-13956
PioglitazonePPARγ Agonist -
HY-17386
RosiglitazonePPARγ Agonist -
HY-B0258
GemfibrozilCytochrome P450 Inhibitor -
HY-14600
Rosiglitazone maleatePPARγ Activator -
HY-17386R
Rosiglitazone (Standard)PPARγ Agonist -
HY-N2853
D-α-TocopherylquinoneQuinone -
HY-125783
1-Palmitoyl-sn-glycero-3-phosphocholineLysophosphatidylcholine -
HY-B0258R
Gemfibrozil (Standard) -
HY-W778336
Girard's Reagent P-d5Stable Isotope -
HY-135430
SRS16-86Ferroptosis Inhibitor -
HY-117761
MHY908PPARα/γ dual agonist -
HY-U00450
4-O-Methyl honokiol
Actividad biológica
Descripciòn
Chemical Information
-
No. CAS 6265-56-1
-
Peso molecular 243.28
-
Fòrmula C13H9NO2S
-
SMILES
OC1=CC=C(C2=NC3=CC=CC=C3S2)C(O)=C1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
MHY 553 Related Classifications
HY-128135 Related Classifications
Powered by Bioz